LINKSciences

LINKSciences LINKSciences is a data firm dedicated to developing integrated tools for scientific & medical data a

The US timeline of COVID-19 from onset to national  ~3 million patients.
07/11/2020

The US timeline of COVID-19 from onset to national ~3 million patients.

COVID 19 Half Year Recap: Top Ranked Countries by Death. Six-month anniversary of the COVID-19 outbreak. This updated ti...
07/08/2020

COVID 19 Half Year Recap: Top Ranked Countries by Death.
Six-month anniversary of the COVID-19 outbreak. This updated timeline details the rank of death for top 15 countries.

June 29 2020 marks six-month anniversary of the COVID-19 outbreak. This updated timeline details the rank of death for top 15 countries.

In June 2016, NIH awarded $2.7 billion funding in 7,030 grants to 6,206 P*s. California is the most awarded states. The ...
07/26/2016

In June 2016, NIH awarded $2.7 billion funding in 7,030 grants to 6,206 P*s. California is the most awarded states. The Johns Hopkins University is the most awarded institution. Top awarded P*s are Gerson, Stanton; Pestell, Richard; and Holmes, King. - See more at: http://blog.linksciences.com/index.php/2016/07/26/the-status-of-research-nih-grant-report-june-2016/

The Status of Research: NIH Grant Report, June 2016 Posted on July 26, 2016 by LINKSciences June 2016 Summary | In June 2016, NIH awarded $2.7 billion funding in 7,030 grants to 6,206 P*s. California is the most awarded states. The Johns Hopkins University is the most awarded institution. Top awarde...

The Snapshot of Erk1: Antibody Citation, Research Trend, and Expert Distribution.http://blog.linksciences.com/index.php/...
07/17/2016

The Snapshot of Erk1: Antibody Citation, Research Trend, and Expert Distribution.

http://blog.linksciences.com/index.php/2016/05/02/erk1-research-trend-expert-distribution-and-antibody-citation/

ERK1: Research Trend, Expert Distribution, and Antibody Citation Posted on May 2, 2016 by LINKSciences ERK1, encoded by MAPK3 mitogen-activated protein kinase 3 (MAPK3) also known as ERT2; ERK-1; PRKM3; P44ERK1; P44MAPK; HS44KDAP; HUMKER1A; p44-ERK1; p44-MAPK. ERK1 is a member of the MAP kinase fami...

Apr 2016: NIH funding $3.2b, grants 7,475, PI 6,654. California, the most awarded state. http://blog.linksciences.com/in...
05/26/2016

Apr 2016: NIH funding $3.2b, grants 7,475, PI 6,654. California, the most awarded state.
http://blog.linksciences.com/index.php/2016/05/24/the-status-of-research-nih-grant-report-april-2016/

The Status of Research: NIH Grant Report, April 2016 Posted on May 24, 2016 by LINKSciences April 2016 Summary | In April 2016, NIH awarded $3.2 billion funding in 7,475 grants to 6,654 P*s. California is the most awarded states. The Johns Hopkins University is the most awarded institution. Top awar...

The Snapshot of c-Myc: Antibody Citation, Research Trend, and Expert Distribution.http://blog.linksciences.com/index.php...
04/20/2016

The Snapshot of c-Myc: Antibody Citation, Research Trend, and Expert Distribution.

http://blog.linksciences.com/index.php/2016/04/19/c-myc-antibody-citation-research-trend-and-expert-distribution/

The Snapshot of c-Myc: Antibody Citation, Research Trend, and Expert Distribution Posted on April 19, 2016 by LINKSciences c-Myc is a multifunctional, nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. It functions as a transcription factor tha…

The Status of Research is strong, as NIH funding goes up.http://blog.linksciences.com/index.php/2016/04/14/nih-grant-rep...
04/14/2016

The Status of Research is strong, as NIH funding goes up.
http://blog.linksciences.com/index.php/2016/04/14/nih-grant-report-march-2016/

The Status of Research: NIH Funding Report, March 2016 Posted on April 14, 2016 by LINKSciences March 2016 Summary | In March 2016, NIH awarded $1.6 billion funding in 3,927 grants to 3,600 P*s. California is the most awarded state, Johns Hopkins is the most awarded institution, top awarded P*s are…

TIM-3 is an emerging target beside PD-1. View its research trend. http://goo.gl/qexDgY
04/11/2016

TIM-3 is an emerging target beside PD-1. View its research trend. http://goo.gl/qexDgY

Article preview View full access options Nature Reviews Clinical Oncology | Research Highlight Print Share/bookmark Cite U Like Facebook Twitter Delicious Digg Google+ LinkedIn Reddit StumbleUpon Previous article Nature Reviews Clinical Oncology | Research Highlights Gastrointestinal cancer: PICCOLO…

Address

Baltimore, MD

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

410-656-9899

Alerts

Be the first to know and let us send you an email when LINKSciences posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The School

Send a message to LINKSciences:

Shortcuts

Share